This site is intended for healthcare professionals only
LoginRegister
Bombay HC Quashes 3% Reservation in Goa Medical Colleges for Children of Govt or Private Sector EmployeesBombay HC Notice to CDSCO on Denial of Phase I Trial for Indigenous Cancer Drug
Carlyle to offload up to 10 percent stake in Piramal Pharma in Rs 26-27 billion deal: ReportPiramal Pharma Turbhe facility gets USFDA EIR
Dr Reddys Secures CDSCO Panel Approval to Import, Market Olutasidenib for AMLOpen to expand US manufacturing as tariff threat looms: Dr Reddy's Labs
USFDA issues EIR for Cohance Lifesciences Telangana facilityUSFDA successfully completes inspection at Solara Ambernath facility
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag InternationalIcotrokinra results show significant skin clearance in patients with difficult to treat scalp,...
India Cuts API Imports, Disburses Rs 1,008 Cr Under PLI Schemes, Parliament ToldDTAB Approves Notification System for Application of new drug, IND for clinical trial, BA-BE study
CDSCO Launches One-Year Online Dual Use NOC System for Bulk Drug ImportsCDSCO Revises Public Hearing Schedule
Bayer Nubeqa gets EU approvalBayer seeks Japenese nod for Aflibercept to treat macular edema following retinal vein occlusion
Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion dealEli Lilly announces transitions in executive leadership
No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in IndiaZealand Pharma announces closing of collaboration, license agreement with Roche
Telangana NSQ DrugsNo Medicine Shortage: AIOCD Appeals to Chemists to Stay Alert and Serve as 'Jan Swasthya Rakshak'
Delhi HC Declines Stay on Medipol Pharmas Debarment Over Substandard Clarithromycin, Noscapine, Appoints ArbitratorDelhi HC Clears Mankind Prime Labs' CROSSRELIEF Trademark for Registration
X